27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
On November 8, 2019, OFCCP released another opinion letter clarifying the extent of its jurisdiction...
Read More >
In this episode of Trekking Through Compliance, we consider the episode Wink of an Eye which aired o...
Read More >
The New Jersey Department of Labor and Workforce Development earlier this month released the report ...
Read More >
The Occupational Safety and Health Administration (“OSHA”) issued a news release stating that Crod...
Read More >
It seems as though there is a minefield that employers must navigate to ensure that they fulfill the...
Read More >
Happy New Year! Did I Miss My Chance at Opportunity Zones? Opportunity zones were introduced in 201...
Read More >